![Peter Farmakis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Farmakis currently works at Covira Surgical, Inc., as Chief Executive Officer & Director, 32 Biosciences, Inc., as Chairman & Chief Executive Officer from 2023, and VitaHEAT Medical Holdings LLC, as Manager.
| Sociétés | Poste | Début |
|---|---|---|
VitaHEAT Medical Holdings LLC
 VitaHEAT Medical Holdings LLC Medical SpecialtiesHealth Technology Manufactures medical devices | Corporate Officer/Principal | - |
Covira Surgical, Inc.
 Covira Surgical, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
VitaHEAT Medical Holdings LLC
VitaHEAT Medical Holdings LLC Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Covira Surgical, Inc.
Covira Surgical, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
